250mg Gefitinib Tablets IP is a medication used in the treatment of certain types of cancer, particularly non-small cell lung cancer (NSCLC) that has specific mutations in the epidermal growth factor receptor (EGFR) gene. It is also known by its brand name Iressa. Gefitinib is a targeted therapy that works by inhibiting the activity of the EGFR protein, which is involved in the growth and division of cancer cells. By blocking this protein, gefitinib helps slow down or stop the growth of cancer cells in individuals with EGFR-mutated NSCLC. 250mg Gefitinib Tablets IP n is taken orally in tablet form. The dosage and treatment schedule will be determined by a healthcare professional based on factors such as the specific mutation, overall health, and other treatments being used.
Brand Name |
Xtinib |
Packaging Sizes |
30 Tablet |
Treatment |
Anti-Cancer Medication |
Storage |
Store In Cool and Dry Place |
Composition |
Gefitinib |
Dose/Strength |
250 mg |
Manufacturer |
Sarabhai Chemicals |
Packaging Type |
Box |
Shelf Life |
2 Year |
![]() |
BALAJI LIFECARE
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |